Last checked at 1 May 2019 16:20
UK Shareholder Meetings Calendar - Next 7 Days
Thursday 2 MayOld MutualMpac GroupHowden Joinery GroupReachKAZ 3 6
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades5,582
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,651.00
Bid:
1,651.00
Ask:
1,652.00
Change:
11.50 (0.70%)
Spread:
1.00 (0.061%)
Open:
1,650.50
High:
1,656.00
Low:
1,637.00
Prev. Close:
1,639.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.1 May 2019 12:36
TOP NEWS: Vaccine Sales Jump-Start GlaxoSmithKline First Quarter
LONDON (Alliance News) - GlaxoSmithKline PLC on Wednesday reported a rise in profit for the first quarter of the year, led by a continuing rise in vaccine sales.The pharmaceutical firm of
Read more1 May 2019 12:31
GlaxoSmithKline Q1 revenues boosted by shingles vaccine
(Sharecast News) - GlaxoSmithKline posted a rise in first-quarter sales on Wednesday as its vaccines division benefited from strong US sales of shingles vaccine Shingrix.
Read more1 May 2019 10:39
Venture Life Hires Former Glaxo Executive To Lead Finance Department
LONDON (Alliance News) - Self-care products firm Venture Life Group PLC on Wednesday announced the appointment of former GlaxoSmithKline PLC executive Andrew Waters as chief financial who joins of
Read more29 Apr 2019 12:24
Glaxo's ViiV Healthcare Submits New Drug Application For HIV Treatment
LONDON (Alliance News) - GlaxoSmithKline PLC on Monday said ViiV Healthcare is seeking US Food & Drug Administration approval for the investigational, monthly, injectable, two-drug regimen of
Read more24 Apr 2019 16:06
UK Earnings, Trading Statements Calendar - Next 7 Days
Thursday 25 April Acacia MiningQ1 ResultsRELXTrading AmericanQ1 Year 26 Year of
Read more24 Apr 2019 15:27
Glaxo To Invest USD100 Million In US Vaccine Manufacturing Site
LONDON (Alliance News) - GlaxoSmithKline PLC said on Wednesday it will invest USD100 million in its manufacturing site in Montana, US, to expand long-term vaccine manufacturing particular, the 100
Read more24 Apr 2019 12:44
Wednesday broker round-up
(Sharecast News) - Saga: JP Morgan upgrades to neutral with a target price of 80p.
Read more18 Apr 2019 10:48
Silence Therapeutics Interim Finance Chief Quinn Appointed Permanently
LONDON (Alliance News) - Silence Therapeutics PLC said on Thursday Interim Chief Financial Officer Rob Quinn has been promoted to the role on a permanent basis with immediate effect.He will
Read more17 Apr 2019 08:22
Persimmon Appoints Glaxo VP As Independent Non-Executive Director
LONDON (Alliance News) - Persimmon PLC on Wednesday said it appointed Claire Thomas as independent non-executive director with effect from August 1.Thomas has been senior vice president at
Read more9 Apr 2019 07:29
GSK gets US green light for two-drug HIV treatment
(Sharecast News) - GlaxoSmithkline said its two drug HIV treatment had been granted US market approval.
Read more9 Apr 2019 06:58
GlaxoSmithKline Notes Approval Of HIV Drug Dovato In US
LONDON (Alliance News) - GlaxoSmithKline PLC on Monday said Dovato has been approved in the US as a treatment for HIV-1 infection in adults who have not previously been treated with antiretroviral
Read more5 Apr 2019 12:53
Friday broker round-up
(Sharecast News) - Purplebricks: Berenberg downgrades to sell with a target price of 80p.
Read more3 Apr 2019 11:59
GlaxoSmithKline's Juluca Suppresses HIV For Three Years In Studies
LONDON (Alliance News) - Drug major GlaxoSmithKline PLC on Wednesday noted that HIV treatment Juluca had been shown to maintain its suppression of the virus in patients after three is a two-drug a
Read more25 Mar 2019 17:14
DIRECTOR DEALINGS: Glaxo Senior Vice President Hirons Sells Shares
LONDON (Alliance News) - GlaxoSmithKline PLC on Monday said that Senior Vice President for global ethics and compliance Nick Hirons sold around GBP350,000 in shares.Hirons sold 22,178 on at
Read more